Brawn Biotech Ltd. (BSE: 530207) is a New Delhi, Delhi-based company in the Health Care Distributors industry. With a market capitalisation of ₹8 Cr, it ranks #5,185 by market cap among the 6,137 Indian listed companies on FinBizNet, and #11 of 11 in Health Care Distributors. At ₹25.40 (as of 25 Oct 2026), the share price is 1.2% below its 52-week high of ₹25.70 and 43.4% above its 52-week low of ₹17.71. The share price is up 17.9% over one year and up 8.6% over three months.
| Current Price | ₹25.40 |
|---|---|
| Market Cap | ₹8 Cr |
| BSE Code | 530207 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| P/E Ratio | 8.1 |
| Return on Equity | 24.43% |
| Return on Assets | -0.22% |
| 52-Week Range | ₹17.71 – ₹25.70 |
| 1-Year Price Change | +17.9% |
| 3-Month Price Change | +8.6% |
| Beta (1Y) | 0.34 |
| Dividend Yield | 0.00% |
| Headquarters | New Delhi, Delhi |
| Website | www.brawnbiotech.com |
Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.
1. Pharmaceuticals-This segment engages in the wholesale of pharmaceutical and medical products. 2. Fabric-0 3. Segment Adjustment-This segment manufactures and sells suiting fabrics.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹181 Cr | 53.1 | 7.99% | — | +48.6% |
| Vaidya Sane Ayurved Laboratories | ₹169 Cr | — | 11.99% | — | -43.5% |
| Achyut Healthcare Ltd | ₹139 Cr | 463.1 | 0.95% | — | +15.0% |
| Balaxi Pharmaceuticals Ltd | ₹122 Cr | 85.9 | 0.59% | ₹81 Cr | -50.2% |
| Chanfta Bhagat Pharma Ltd | ₹30 Cr | 9.9 | 2.91% | — | -5.1% |
| Medico Intercontinental Ltd | ₹25 Cr | -7.8 | -27.14% | ₹14 Cr | -34.9% |
| Zenlabs Ethica Ltd | ₹18 Cr | -10.1 | -20.44% | — | -12.8% |
| Rubra Medicaments Ltd. | ₹18 Cr | 11.9 | 12.67% | — | -37.7% |
| Brawn Biotech Ltd. | ₹8 Cr | 8.1 | 24.43% | — | +17.9% |
Listed by market capitalisation. Ratios are shown for context only.
Brawn Biotech Ltd. is trading at ₹25.40, with a market capitalisation of ₹8 Cr.
Brawn Biotech Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Brawn Biotech Ltd. has a P/E of 8.1 and a return on equity of 24.43%.
Brawn Biotech Ltd. is listed on the BSE under the scrip code 530207.
Brawn Biotech Ltd.'s share price is up 17.9% over one year and up 8.6% over three months. Its 52-week range is ₹17.71 to ₹25.70.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.